0

Nephrology Collection
 41-60 of 90 Articles
ACP Journal Club |  21 June 2011
Review: Antihypertensive treatment prevents cardiovascular events and mortality in cardiovascular disease without hypertension
Jay N. Cohn, MD
Ann Intern Med. 2011;154(12):JC6-6. doi:10.7326/0003-4819-154-12-201106210-02006
ACP Journal Club |  21 June 2011
Candesartan did not improve clinical or functional outcomes in patients with acute stroke and elevated BP
Rick Frieden, MD
Ann Intern Med. 2011;154(12):JC6-5. doi:10.7326/0003-4819-154-12-201106210-02005
ACP Journal Club |  17 May 2011
Review: Low-dose hydrochlorothiazide is not as effective as other antihypertensive drugs for reducing ambulatory BP in hypertension?
Eugene Yang, MD, FACC
Ann Intern Med. 2011;154(10):JC5-8. doi:10.7326/0003-4819-154-10-201105170-02008
ACP Journal Club |  17 May 2011
In hemodialysis patients with CHF, adding telmisartan to standard ACE inhibitors reduced CHD mortality and admissions
Reem Mustafa, MD, MPH; Amit X. Garg, MD, PhD
Ann Intern Med. 2011;154(10):JC5-5. doi:10.7326/0003-4819-154-10-201105170-02005
ACP Journal Club |  19 April 2011
Increased frequency of hemodialysis reduced adverse clinical outcomes
Gihad E. Nesrallah, MD
Ann Intern Med. 2011;154(8):JC4-6. doi:10.7326/0003-4819-154-8-201104190-02006
ACP Journal Club |  15 March 2011
Hormone therapy increased risk for kidney stones in healthy postmenopausal women
Donna Fedorkow, MD
Ann Intern Med. 2011;154(6):JC3-10. doi:10.7326/0003-4819-154-6-201103150-02010
ACP Journal Club |  15 February 2011
Pharmacist–physician hypertension comanagement reduced 24-hour ambulatory blood pressure
Brett D. Montgomery, MBBS, DCH, FRACGP
Ann Intern Med. 2011;154(4):JC2-9. doi:10.7326/0003-4819-154-4-201102150-02009
ACP Journal Club |  16 November 2010
Review: Erythropoiesis-stimulating agents targeted to higher hemoglobin levels increase risk for adverse outcomes in CKD
Chi-yuan Hsu, MD, MSc
Ann Intern Med. 2010;153(10):JC5-3. doi:10.7326/0003-4819-153-10-201011160-02003
ACP Journal Club |  16 November 2010
Early and late initiation of dialysis did not differ for reduction of all-cause mortality in stage 5 chronic kidney disease
Michael Walsh, MD, MSc
Ann Intern Med. 2010;153(10):JC5-2. doi:10.7326/0003-4819-153-10-201011160-02002
ACP Journal Club |  19 October 2010
Benazepril plus amlodipine reduced CV events more than benazepril plus hydrochlorothiazide in hypertension with or without diabetes
Srinivas Merugu, MD
Ann Intern Med. 2010;153(8):JC4-2. doi:10.7326/0003-4819-153-8-201010190-02002
ACP Journal Club |  20 July 2010
Intensive blood pressure control did not prevent major CV events more than standard control in type 2 diabetes
C. Raina Elley, MBChB, PhD; Vanessa Selak, MBChB, MPH
Ann Intern Med. 2010;153(2):JC1-4. doi:10.7326/0003-4819-153-2-201007200-02004
ACP Journal Club |  15 June 2010
Aspirin did not prevent vascular events or mortality in adults with a low ankle–brachial index
A.C. Felix Burden, MD
Ann Intern Med. 2010;152(12):JC6-11. doi:10.7326/0003-4819-152-12-201006150-02011
ACP Journal Club |  15 June 2010
Valsartan reduced diabetes but not CV events in patients with impaired glucose tolerance and CV risk factors
Michael Farkouh, MD, MSc
Ann Intern Med. 2010;152(12):JC6-9. doi:10.7326/0003-4819-152-12-201006150-02009
ACP Journal Club |  15 June 2010
Stent grafts were more effective than balloon angioplasty alone for revision of stenosis in failing dialysis-access grafts
Louise Moist, MD, MSc
Ann Intern Med. 2010;152(12):JC6-8. doi:10.7326/0003-4819-152-12-201006150-02008
ACP Journal Club |  18 May 2010
Review: Evidence on the effectiveness of sodium bicarbonate regimens to prevent contrast-induced nephropathy is unclear
Amit X. Garg, MD, PhD
Ann Intern Med. 2010;152(10):JC5-10. doi:10.7326/0003-4819-152-10-201005180-02010
ACP Journal Club |  18 May 2010
Good evidence supports use of ACE inhibitors in stable ischemic heart disease; little evidence exists for ARBs
Vibhuti Singh, MD, MPH
Ann Intern Med. 2010;152(10):JC5-3. doi:10.7326/0003-4819-152-10-201005180-02003
ACP Journal Club |  16 April 2010
Review: Insufficient evidence exists on the benefit of vitamin D in patients with chronic kidney disease not requiring dialysis
James B. Wetmore, MD
Ann Intern Med. 2010;152(8):JC4-12. doi:10.7326/0003-4819-152-8-201004200-02012
ACP Journal Club |  16 March 2010
Darbepoetin decreased transfusions and fatigue, but increased adverse effects in patients with chronic kidney disease, diabetes, and anemia
Tejas V. Patel, MD, MPH, FACP, FASN
Ann Intern Med. 2010;152(6):JC3-9. doi:10.7326/0003-4819-152-6-201003160-02009
ACP Journal Club |  16 February 2010
Adding revascularization to medical therapy did not improve renal function in atherosclerotic renal artery stenosis
Daniel G. Hackam, MD, PhD; Amit X. Garg, MD, PhD
Ann Intern Med. 2010;152(4):JC2-6. doi:10.7326/0003-4819-152-4-201002160-02006
ACP Journal Club |  16 February 2010
Higher-intensity continuous renal-replacement therapy did not reduce mortality in critically ill patients with kidney injury
Chirag R. Parikh, MD, PhD; Justin Belcher, MD
Ann Intern Med. 2010;152(4):JC2-5. doi:10.7326/0003-4819-152-4-201002160-02005
Advertisement

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)